Cell Reports
Volume 12, Issue 6, 11 August 2015, Pages 992-1005
Journal home page for Cell Reports

Article
The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts

https://doi.org/10.1016/j.celrep.2015.07.010Get rights and content
Under a Creative Commons license
open access

Highlights

  • Global PHD2 haplodeficiency reduces metastasis in a spontaneous cancer model

  • This results from reduced activation of cancer-associated fibroblasts (CAFs)

  • Reduced CAF activation impairs matrix contraction

  • Global PHD2 haplodeficiency after tumor onset still reduces metastasis

Summary

Several questions about the role of the oxygen sensor prolyl-hydroxylase 2 (PHD2) in cancer have not been addressed. First, the role of PHD2 in metastasis has not been studied in a spontaneous tumor model. Here, we show that global PHD2 haplodeficiency reduced metastasis without affecting tumor growth. Second, it is unknown whether PHD2 regulates cancer by affecting cancer-associated fibroblasts (CAFs). We show that PHD2 haplodeficiency reduced metastasis via two mechanisms: (1) by decreasing CAF activation, matrix production, and contraction by CAFs, an effect that surprisingly relied on PHD2 deletion in cancer cells, but not in CAFs; and (2) by improving tumor vessel normalization. Third, the effect of concomitant PHD2 inhibition in malignant and stromal cells (mimicking PHD2 inhibitor treatment) is unknown. We show that global PHD2 haplodeficiency, induced not only before but also after tumor onset, impaired metastasis. These findings warrant investigation of PHD2’s therapeutic potential.

Cited by (0)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).